- Previous Close
301.83 - Open
0.00 - Bid --
- Ask --
- Day's Range
273.00 - 273.00 - 52 Week Range
245.71 - 276.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
94.881B - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
66.71 - EPS (TTM)
4.53 - Earnings Date Feb 25, 2025 - Mar 3, 2025
- Forward Dividend & Yield 24.56 (9.00%)
- Ex-Dividend Date Nov 15, 2024
- 1y Target Est
--
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
www.sabrahealth.com48
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA.MX
View MorePerformance Overview: SBRA.MX
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA.MX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA.MX
View MoreValuation Measures
Market Cap
83.72B
Enterprise Value
132.97B
Trailing P/E
60.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.85
Price/Book (mrq)
1.19
Enterprise Value/Revenue
10.24
Enterprise Value/EBITDA
20.21
Financial Highlights
Profitability and Income Statement
Profit Margin
14.22%
Return on Assets (ttm)
2.83%
Return on Equity (ttm)
3.46%
Revenue (ttm)
683.22M
Net Income Avi to Common (ttm)
97.17M
Diluted EPS (ttm)
4.53
Balance Sheet and Cash Flow
Total Cash (mrq)
73.31M
Total Debt/Equity (mrq)
90.30%
Levered Free Cash Flow (ttm)
235.09M